C V STARR & CO INC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001340459

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedFinancials TiltHigh Turnover how tags are computed

Q2 2026 · 5 positions · Total reported value $187.29M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 1 new · 1 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, C V STARR & CO INC disclosed 5 equity positions with a combined reported value of $187.29M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Financials Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were GLD ($92.61M), IDEV ($33.72M), IJR ($29.73M). By sector, the heaviest allocations are Financials 49.4%, Health Care 0.8%. Versus the prior quarter, allocation shifted toward Other (+6.6pp) and away from Financials (-7.0pp).

Versus the prior quarter, C V STARR & CO INC opened 1 new positions, trimmed 1 and fully exited 0, a turnover rate of 33.3% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest C V STARR & CO INC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

C V Starr files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 5 positions worth $187.29M in total. HoldingsHub carries 7 quarters of its filings (Q4 2024–Q2 2026).

Portfolio Structure

  • 5 positions · $187.29M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: GLD (SPDR GOLD TR) at 49.4%
  • Average position size: $37.46M

Sector Tilt

  • Financials 49.4%
  • Health Care 0.8%
  • (classified holdings cover 50% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a conservative stance, with a preference for holding existing positions rather than making significant changes. This is indicated by the "Hold" action on all top holdings and no new additions. 2. Key Moves: The fund has made no changes to its top holdings, which suggests a commitment to the current portfolio. The absence of additions or deletions indicates a lack of market-driven rebalancing decisions this quarter. 3. Portfolio Structure: - Passive/Active: The portfolio appears to be more passive, as it consists of ETFs and only one individual stock (CELU). - Sector Bias: The sector allocation is primarily in financials, which is the largest sector at 49.45%. The fund also has significant exposure to healthcare (0.84%) and consumer discretionary (15.83% from IVOO). - Risk Appetite: The risk appetite seems moderate, with a focus on diversified exposure rather than high-risk strategies. 4. Per-Holding One-Liner: - GLD: Tracks the price of gold, often used as a safe haven asset. - IDEV: Invests in companies with high expected long-term growth. - IJR: Focuses on the performance of a basket of U.S. small-cap companies. - IVOO: Invests in a basket of U.S. consumer discretionary companies. - CELU: Develops and commercializes therapies for the treatment of blood cancers and related hematologic disorders. - All are 'verified' based on the provided information. 5. One-Sentence Style Summary: The C V STARR & CO INC fund maintained its conservative stance by holding existing positions, reflecting a cautious and diversified investment approach with a focus on financials and consumer discretionary sectors.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Financials 49.4%
Other 49.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 251.40K $92.61M 49.45%
49.45%
Hold
2 378.79K $33.72M 18.00%
18.00%
Hold
3 200.46K $29.73M 15.87%
15.87%
Hold
4 227.43K $29.66M 15.83%
15.83%
Hold
5 764.07K $1.58M 0.84%
0.84%
Hold

FAQ

What did C V STARR & CO INC buy in 2026-Q2?

In its 2026-Q2 13F filing, C V STARR & CO INC reported 5 equity positions worth $187.29M in aggregate; its largest disclosed positions were GLD ($92.61M), IDEV ($33.72M), IJR ($29.73M).

How large is C V STARR & CO INC's portfolio?

C V STARR & CO INC reported $187.29M of long equity holdings across 5 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is C V STARR & CO INC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Financials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/c-v-starr-and/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →